These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10210726)

  • 21. Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin.
    Tokumoto S; Higo N; Sugibayashi K
    Int J Pharm; 2006 Dec; 326(1-2):13-9. PubMed ID: 16920293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.
    Singh G; Ghosh B; Kaushalkumar D; Somsekhar V
    AAPS PharmSciTech; 2008; 9(3):791-7. PubMed ID: 18592380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
    Juluri A; Peddikotla P; Repka MA; Murthy SN
    J Pharm Sci; 2013 Feb; 102(2):500-7. PubMed ID: 23175436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of terpenes on transdermal iontophoretic delivery of diclofenac potassium under constant voltage.
    Arunkumar S; Shivakumar HN; Narasimha Murthy S
    Pharm Dev Technol; 2018 Oct; 23(8):806-814. PubMed ID: 28814142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal iontophoresis of insulin. VI. Influence of pretreatment with fatty acids on permeation across rat skin.
    Pillai O; Panchagnula R
    Skin Pharmacol Physiol; 2004; 17(6):289-97. PubMed ID: 15528959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal iontophoretic delivery of therapeutic peptides/proteins. I: Insulin.
    Chien YW; Siddiqui O; Sun Y; Shi WM; Liu JC
    Ann N Y Acad Sci; 1987; 507():32-51. PubMed ID: 3327418
    [No Abstract]   [Full Text] [Related]  

  • 28. Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers.
    Pillai O; Nair V; Panchagnula R
    Int J Pharm; 2004 Jan; 269(1):109-20. PubMed ID: 14698582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iontophoretic transdermal delivery of haloperidol.
    Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
    Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer.
    Oh SY; Jeong SY; Park TG; Lee JH
    J Control Release; 1998 Feb; 51(2-3):161-8. PubMed ID: 9685913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.
    Meidan VM; Al-Khalili M; Michniak BB
    Int J Pharm; 2003 Oct; 264(1-2):73-83. PubMed ID: 12972337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of transdermal absorption by switching iontophoresis.
    Ishikawa O; Kato Y; Onishi H; Nagai T; Machida Y
    Int J Pharm; 2002 Dec; 249(1-2):81-8. PubMed ID: 12433436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
    Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of microporation on passive and iontophoretic delivery of diclofenac sodium.
    Patel H; Joshi A; Joshi A; Stagni G
    Drug Dev Ind Pharm; 2015; 41(12):1962-7. PubMed ID: 25758411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal iontophoretic drug delivery: advances and challenges.
    Ita K
    J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal delivery of insulin using trypsin as a biochemical enhancer.
    Li YZ; Quan YS; Zang L; Jin MN; Kamiyama F; Katsumi H; Yamamoto A; Tsutsumi S
    Biol Pharm Bull; 2008 Aug; 31(8):1574-9. PubMed ID: 18670091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical iodine facilitates transdermal delivery of insulin.
    Sintov AC; Wormser U
    J Control Release; 2007 Apr; 118(2):185-8. PubMed ID: 17270303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.
    Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC
    AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal Delivery of Insulin Using Combination of Iontophoresis and Deep Eutectic Solvents as Chemical Penetration Enhancers: In Vitro and in Vivo Evaluations.
    Khamoushian S; Madrakian T; Afkhami A; Ghoorchian A; Ghavami S; Tari K; Samarghandi MR
    J Pharm Sci; 2023 Aug; 112(8):2249-2259. PubMed ID: 36921801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.